Valuation: Compumedics Limited

Market Cap 43.95M 30.44M 26.75M 24.97M 22.91M 42.89M 2.92B 296M 116M 1.44B 114M 112M 4.99B P/E 2026 *
14.7x
P/E 2027 * 5.95x
Enterprise Value 43.95M 30.44M 26.75M 24.97M 22.91M 42.89M 2.92B 296M 116M 1.44B 114M 112M 4.99B EV / Sales 2026 *
0.66x
EV / Sales 2027 * 0.55x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 9.09%
1 day-8.33%
1 week-10.20%
Current month-13.73%
1 month-8.33%
3 months-26.67%
6 months-48.84%
Current year-34.33%
1 week 0.22
Extreme 0.215
0.24
1 month 0.22
Extreme 0.215
0.3
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
-8.33%-10.20%-31.25%+29.41% 33.45M
+0.01%+9.50%+19.56%+5.07% 214B
-1.29%+9.69%-5.01%-22.96% 140B
-2.40%+3.64%-28.94%+8.85% 128B
-0.04%+7.14%-56.76%-11.21% 68.46B
+2.49%+1.65%+6.57%+4.50% 48.18B
+4.51%+8.78%-21.58%-28.66% 45.56B
-0.17%+5.13%+17.07%+15.22% 39.69B
-1.15%+2.34%+25.16%+37.39% 37.69B
+2.55%+11.08%-22.83%-3.62% 30.14B
Average -0.28%+3.86%-9.80%+3.40% 75.17B
Weighted average by Cap. -0.05%+5.29%-5.09%-1.26%

Financials

2026 *2027 *
Net sales 66.3M 45.92M 40.35M 37.66M 34.57M 64.7M 4.4B 447M 175M 2.18B 172M 169M 7.52B 79.7M 55.2M 48.51M 45.28M 41.55M 77.78M 5.29B 537M 210M 2.62B 207M 203M 9.04B
Net income 3.8M 2.63M 2.31M 2.16M 1.98M 3.71M 252M 25.6M 10.01M 125M 9.88M 9.67M 431M 9M 6.23M 5.48M 5.11M 4.69M 8.78M 597M 60.63M 23.71M 295M 23.4M 22.9M 1.02B
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
29/07/26 A$0.2200 -8.33% 25,561
28/07/26 A$0.2400 0.00% 4,166
27/07/26 A$0.2400 +4.35% 5,000
22/07/26 A$0.2300 -6.12% 2,400
21/07/26 A$0.2450 +13.95% 9,802
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2200AUD
Average target price
0.8000AUD
Spread / Average Target
+263.64%

Annual profits - Rate of surprise